Send to a Friend Share

Pernix Therapeutics (PTX) Announces $25M Offering

February 10, 2012 4:25 PM EST
PTX Hot Sheet
Overall Analyst Rating:
    BUY (= Flat)

EPS Growth %: +114.3%
Pernix Therapeutics (NYSE: PTX) may sell up to $25 million in common shares.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Equity Offerings

Add Your Comment





Follow StreetInsider.com On Twitter